InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-6.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Mahoney Michael F, Director. Director active across 3 companies, notably Baxter International INC. In total, 69 reports have been published. Split: 3 buys · 6 sells. Total volume traded: €44.9m. Activity tracked since 4 May 2021. The latest transaction was disclosed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mahoney Michael F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations69 total
186,240 shares@ US$48.3323Common StockSEC:0001225208-26-006950:0
Canonical exit: 1 Nov 2026 (T+90)
22,119 shares@ US$48.43Common StockSEC:0001225208-26-006950:1
386,755 shares0Common StockSEC:0001225208-26-005670:0
132,190 shares0Common StockSEC:0001225208-26-002135:0
13,704 shares0Common StockSEC:0001225208-26-002016:0
49,407 shares@ US$24.552.0% of flowCommon StockSEC:0001225208-26-001156:0
88,197 shares0Common StockSEC:0001225208-25-008843:0
56,212 shares@ US$17.261.7% of flowCommon StockSEC:0001225208-25-005681:0
144 shares@ US$60.470.3% of flowCommon StockSEC:0001127602-25-014956:0
56,212 shares@ US$17.261.6% of flowCommon StockSEC:0001225208-25-004717:0
56,211 shares@ US$17.261.7% of flowCommon StockSEC:0001225208-25-003866:0
30,000 shares@ US$66.7069.8% of flowCommon Stock (By Trust)SEC:0001127602-25-005398:0
Canonical exit: 19 May 2025 (T+90)
16,524 shares0Common StockSEC:0001225208-25-001871:0
13,704 shares0Common StockSEC:0001225208-25-001792:0
130,118 shares0Common StockSEC:0001225208-25-001684:0
57,121 shares0Common StockSEC:0001225208-25-000205:0
7,800 shares0Common StockSEC:0001225208-24-010259:0
2,200 shares@ US$57.104.4% of flowCommon StockSEC:0001127602-24-028001:0
56,211 shares@ US$17.261.7% of flowCommon StockSEC:0001225208-24-009728:0
56,211 shares@ US$17.261.7% of flowCommon StockSEC:0001225208-24-009234:0
55,675 shares@ US$16.311.6% of flowCommon StockSEC:0001225208-24-009234:1
80,692 shares@ US$84.312711.7% of flowCommon StockSEC:0001225208-24-009234:2
82,085 shares@ US$84.941612.0% of flowCommon StockSEC:0001225208-24-009234:3
56,211 shares@ US$17.261.7% of flowCommon StockSEC:0001225208-24-008529:0
176,245 shares0Common StockSEC:0001225208-24-008332:2
25 of 69 declarations
About Mahoney Michael F
Mahoney Michael F is a director, and he is also Chairman, President & CEO of Boston Scientific CORP, as well as a director of CVS HEALTH Corp and Baxter International INC. The 67 filings recorded cover the period from 2016-01-05 to 2026-06-01; across this full sample, buys total 2374497 EUR and sells total 34679722 EUR, with Levée d'options as the most frequent transaction nature.
